Friday 6 November 2026 Export DNTH’s income statement to Excel — free account

Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 million, down 67.3% from fiscal 2024.

Revenue: +205.6%
EPS: +16.1%
Free cash flow: −65.9%

Quarter to September 2026, against a year earlier

86.43 3.42 +4.12%

Follow DNTH

Alert me

Market cap: $4.6B
P/E: 0.0×
Fwd P/E: −21.5×
Dividend yield: —
F-score: 2/9
Altman Z: 24.31
Beneish M: −4.75
Dividend safety: n/a

Overview

Dianthus Therapeutics, Inc. (DNTH) P/B ratio

Alert me on P/B ratio

As of 6 November 2026, Dianthus Therapeutics, Inc. (DNTH) trades at a P/B ratio of 4.0×. Over the past ten years it has ranged from 0.0× (March 2023) to 6.8× (March 2026); the current reading is higher than 91% of that period. That is above the Biotechnology industry median of 2.1× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/DNTH/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Dianthus Therapeutics, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/DNTH/metrics/pb-ratio">Dianthus Therapeutics, Inc. (DNTH) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	3.2×	56.54%
FY2024	2.1×	489.70%
FY2023	0.3×	—
FY2022	0.0×	—

Period	P/B ratio	Change
Sep 2026	4.1×	(12.73%)
Jun 2026	4.7×	38.88%
Mar 2026	3.4×	4.03%
Dec 2025	3.2×	18.52%
13 more quarters	Free account

Against its own ten years

Low 0.0× High 6.8×

Ten-year median 2.1×

Current reading's percentile 90

Company	P/B ratio
CRSP CRISPR Therapeutics AG compare	2.9×
EWTX Edgewise Therapeutics, Inc. compare	3.0×
LEGN Legend Biotech Corporation Sponsored ADR compare	3.6×
DNTH Dianthus Therapeutics, Inc.	4.0×
DFTX Definium Therapeutics, Inc. compare	4.0×
MANE Veradermics Incorporated compare	6.9×
COGT Cogent Biosciences, Inc. compare	11.6×
ERAS Erasca, Inc. compare	12.3×
TVTX Travere Therapeutics, Inc. compare	207×
Biotechnology industry median	2.1×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Dianthus Therapeutics, Inc. (DNTH) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on DNTH

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on DNTH

Stockrow Weekly